A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURO bservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry

Europace

Volumn 16, Issue 3, 2014, Pages 308-319

  Lip, Gregory Y H ^a   Laroche, Cécile ^b   Dan, Gheorghe Andrei ^c   Santini, Massimo ^d   Kalarus, Zbigniew ^e,n   Rasmussen, Lars Hvilsted ^f   Oliveira, Mário Martins ^g   Mairesse, Georges ^h   Crijns, Harry J G M ^i,n   Simantirakis, Emmanouil ^j   Atar, Dan ^k   Kirchhof, Paulus ^a,l   Vardas, Panos ^j,n   Tavazzi, Luigi ^m   Maggioni, Aldo P ^b   Raepers, M ⁿ   El Husseini, Z ⁿ   Dilling Boer, D ⁿ   Schurmans, J ⁿ   Vijgen, J ⁿ   Koopman, P ⁿ   Huybrechts, W ⁿ   Dormal, F ⁿ   Blommaert, D ⁿ   Deceuninck, O ⁿ   Xhaet, O ⁿ   Fragtrup Hellum, C ⁿ   Mortensen, B ⁿ   Ginnerup Sorensen, B ⁿ   Joensen, A M ⁿ   Rasmussen, L H ⁿ   Karlsdottir, A ⁿ   Pehrson, S ⁿ   Hummelshoj, J ⁿ   Svenningsen, A M ⁿ   Tanggaard, L ⁿ   Wiggers, P ⁿ   Nygaard, A ⁿ   Jonstrup, A ⁿ   Petersen, J ⁿ   Odgaard, A ⁿ   Mortensen, M ⁿ   Frost, L ⁿ   Svenstrup Moller D ⁿ   Sondergaard H M ⁿ   Christensen, P D ⁿ   Xydonas, S ⁿ   Lioni, L ⁿ   Dimopoulou, M ⁿ   Georgiopoulos, G ⁿ   Papatheodorou, E ⁿ   Boutas, P ⁿ   Kartalis, A ⁿ   Nakou, H ⁿ   Kanoupakis, E ⁿ   Simantirakis, E ⁿ   Tahmatzidis, D ⁿ   Styliadis, I ⁿ   Vassilikos, V ⁿ   Koskinas, K ⁿ   Fragakis, N ⁿ   Polymeropoulos, K ⁿ   Maligos, G ⁿ   Martignani, C ⁿ   Diemberger, I ⁿ   Boriani, G ⁿ   Frisoni, J ⁿ   Biffi, M ⁿ   Ziacchi, M ⁿ   Cimaglia, P ⁿ   Fantecchi, E ⁿ   Boni, S ⁿ   Gabbai, D ⁿ   Marchionni, N ⁿ   Fumagalli, S ⁿ   Bobbo, M ⁿ   Ramani, F ⁿ   Sinagra, G ⁿ   Vitali Serdoz, L ⁿ   Nordio, A ⁿ   Porto, A ⁿ   Zecchin, M ⁿ   Di Nora, C ⁿ   Novo, S ⁿ   Guarneri, F P ⁿ   MacAione, F ⁿ   Rod R ⁿ   Stodle R M O ⁿ   Pervez, M O ⁿ   Smith, P ⁿ   Buvarp, M ⁿ   Ronnevik P K ⁿ   Vold, A ⁿ   Fuglestved, J ⁿ   Atar, D ⁿ   Stenshjemmet, E ⁿ   Risberg, K ⁿ   Sokal, A ⁿ   Kubicius, A ⁿ   Prochniewicz, E ⁿ   Pokrywa, K ⁿ   Rzeuski, R ⁿ   Weryszko, A ⁿ   Haberka, M ⁿ   Gasior, Z ⁿ   Slowikowski, A ⁿ   Janion, M ⁿ   Kolodziej M ⁿ   Janion Sadowska, A ⁿ   Drozdz, J ⁿ   Stasiak, M ⁿ   Jakubowski, P ⁿ   Ciurus, T ⁿ   Pawlak, M ⁿ   Nowakowska, M ⁿ   Wiklo, K ⁿ   Kurpesa, M ⁿ   Olejnik, A ⁿ   Miarka, J ⁿ   Streb, W ⁿ   Zielinski, L ⁿ   Dluzniewski, M ⁿ   Tomaszewska Kiecana, M ⁿ   Opolski, G ⁿ   Budnik, M ⁿ   Kiliszek, M ⁿ   Gorska, J ⁿ   Mamcarz, A ⁿ   Sliz, D ⁿ   Makowiecki, K ⁿ   Fuglewicz, A ⁿ   Drozd, M ⁿ   Garncarek, M ⁿ   Musialik Lydka, A ⁿ   Markowicz Pawlus, E ⁿ   Kazmierczak G ⁿ   Leopold Jadczyk, A ⁿ   Koziel, M ⁿ   Sobral, S ⁿ   Pereira, H ⁿ   Brandao Alves, L ⁿ   Ribeiro, L ⁿ   Miranda, R ⁿ   Almeida, S ⁿ   Madeira, F ⁿ   Faustino, M ⁿ   Oliveira, R ⁿ   Gil, V ⁿ   Braga, C ⁿ   Martins, J ⁿ   Rocha, S ⁿ   Magalhaes, S ⁿ   Ramos, V ⁿ   Bernardo, R ⁿ   Costa, F ⁿ   Morgado, F ⁿ   Galvao Santos, P ⁿ   Almeida, N ^n,n   Adragao, P ^n,n   Carmo, P ^n,n   Mariano Pego, G ⁿ   Ferreira, J ⁿ   Elvas, L ⁿ   Ventura, M ⁿ   Antonio N ⁿ   Ferreira, R ⁿ   Damasio, A F ⁿ   Santos, A R ⁿ   Picarra B ⁿ   Neves, D ⁿ   De Jesus, I ⁿ   Amado, J ⁿ   Sousa, P ⁿ   Candeias, R ⁿ   Lourenco, A ⁿ   Pereira, A ⁿ   Canario Almeida F ⁿ   Fernandes, M ⁿ   Ferreira, F ⁿ   MacHado, I ⁿ   Quelhas, I ⁿ   Guardado, J ⁿ   Pereira, V ⁿ   Cavaco, D ⁿ   Lousinha, A ⁿ   Valente, B ⁿ   Silva, N ⁿ   Cunha, P ⁿ   Pimenta, R ⁿ   Santos, S ⁿ   Martins Oliveira, M ⁿ   Vicente, S ⁿ   Bernardes, A ⁿ   Nunes Diogo, A ⁿ   Rodrigues, E ⁿ   Frazao Rodrigues De Sousa, J M ⁿ   Carpinteiro, L ⁿ   Satendra, M ⁿ   Cortez Dias, N ⁿ   Neto, S ⁿ   Gama Ribeiro, V ⁿ   Goncalves H ⁿ   Primo, J ⁿ   Adao, L ⁿ   Oliveira, M ⁿ   Costa, A ⁿ   Delgado, A ⁿ   Marmelo, B ⁿ   Moreira, D ⁿ   Santos, J ⁿ   Santos, L ⁿ   Rodrigues, B ⁿ   Pop Moldovan, A ⁿ   Darabantiu, D ⁿ   Todea, B ⁿ   Pop, C ⁿ   Dicu, D ⁿ   Filip, D ⁿ   Mercea, D ⁿ   Kozma, G ⁿ   Schiopu, M ⁿ   Catanescu, G ⁿ   Popescu, C ⁿ   Bobescu, E ⁿ   Gabor, A ⁿ   Buzea, A ⁿ   Dan, A ⁿ   Buzea Daha, I ⁿ   Asan, N ⁿ   Popescu, R ⁿ   Dan, G A ⁿ   Bartos, D ⁿ   Badila, E ⁿ   Tintea, E ⁿ   Grigore, C ⁿ   Daraban, A M ⁿ   Sandulescu, A ⁿ   Carp, A ⁿ   Gherasim, D ⁿ   Stoian, I M ⁿ   Baluta, M M ⁿ   Vintila, M M ⁿ   Popescu, M I ⁿ   Tica, O ⁿ   Petrescu, L ⁿ   Alina Ramona, N ⁿ   Dan, R ⁿ   Cozma, D C ⁿ   Tutuianu, C ⁿ   Mangea, M ⁿ   Goanta, E ⁿ   Van Opstal, J M ⁿ   Van Rennes, R ⁿ   Mulder, B A ⁿ   Said, S A M ⁿ   Folkeringa, R J ⁿ   Philippens, S ⁿ   Blaauw, Y ⁿ   Aksoy, I ⁿ   Pluymen, M ⁿ   Driessen, R ⁿ   Limantoro, I ⁿ   Lankveld, T ⁿ   Mafi Rad, M ⁿ   Hendriks, J ⁿ   Van Unen, W H ⁿ   Meeder, J ⁿ   more..

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b European Society of Cardiology   (France)

^c CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d SAN FILIPPO NERI HOSPITAL   (Italy)

^e MEDICAL UNIVERSITY OF SILESIA   (Poland)

^f AALBORG UNIVERSITY HOSPITAL   (Denmark)

^g INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^h Cliniques du Sud Luxembourg Vivalia   (Belgium)

ⁱ MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^j UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^k OSLO UNIVERSITY HOSPITAL   (Norway)

^l UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^m MARIA CECILIA HOSPITAL   (Italy)

ⁿ Heraklion University Hospital ^*  (Netherlands)

more..

Author keywords

Anticoagulation; Atrial fibrillation; Registry; Risk scores

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; APIXABAN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DABIGATRAN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISOPYRAMIDE; DIURETIC AGENT; DRONEDARONE; FLECAINIDE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDOBUFEN; INSULIN; PRASUGREL; PROPAFENONE; QUINIDINE; RIVAROXABAN; SOTALOL; TICAGRELOR; TICLOPIDINE;

AGED; ARTICLE; ASYMPTOMATIC DISEASE; BODY MASS; CARDIOLOGIST; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HYPERTENSION; HYPERTHYROIDISM; IMPLANTED HEART PACEMAKER; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; THYROID FUNCTION TEST; TRANSTHORACIC ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE;

ANTICOAGULATION; ATRIAL FIBRILLATION; REGISTRY; RISK SCORES;

ADMINISTRATION, ORAL; ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; CAUSALITY; COMORBIDITY; EUROPE; FEMALE; FIBRINOLYTIC AGENTS; HEALTH CARE SURVEYS; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PILOT PROJECTS; PREVALENCE; REGISTRIES; RISK FACTORS; THROMBOSIS; TREATMENT OUTCOME;

EID: 84895729096     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut373     Document Type: Article

References (20)

1. Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060 Eur Heart J 2013; doi:10.1093/eurheartj/ eht280.
2. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association. Europace 2012;14:1385-413.
3. Nieuwlaat R, Capucci A, Camm AJ, Olsson SB, Andresen D, Davies DW, et al. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on atrial fibrillation. Eur Heart J 2005;26:2422-34.
4. Nieuwlaat R, Capucci A, Lip GY, Olsson SB, Prins MH, Nieman FH et al. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on atrial fibrillation. Eur Heart J 2006;27:3018-26.
5. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest 2010; 137:263-72.
6. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (has-bled) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010;138:1093-100.
7. Lip GY. EUR observational research programme: atrial fibrillation general registry pilot phase. Eur Heart J 2013;34:794.
8. Nabauer M, Gerth A, Limbourg T, Schneider S, Oeff M, Kirchhof P et al. The Registry of the German Competence Network on Atrial Fibrillation: patient characteristics and initial management. Europace 2009;11:423-34.
9. Kirchhof P, Ammentorp B, Darius H, De Caterina R, Le Heuzey JY, Schilling RJ et al. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC guidelines on atrial fibrillation: primary results of the prevention of thromboemolic events-European Registry in Atrial Fibrillation (prefer in AF). Europace 2013; doi:10.1093/europace/eut263.
10. Wilke T, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R et al. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients. Thromb Haemost 2012;107:1053-65.
11. Potpara TS, Lip GY. Lone atrial fibrillation: what is known and what is to come. Int J Clin Pract 2011;65:446-57.
12. Kirchhof P, Lip GY, Van Gelder IC, Bax J, Hylek E, Kaab S et al. Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options-a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. Europace 2012;14:8-27.
13. Kirchhof P, Nabauer M, Gerth A, Limbourg T, Lewalter T, Goette A et al. Impact of the type of centre onmanagement of AF patients: surprising evidence for differences in antithrombotic therapy decisions. Thromb Haemost 2011;105:1010-23.
14. Lip GY. Recommendations for thromboprophylaxis in the 2012 focused update of the ESC guidelines on atrial fibrillation: a commentary. J Thromb Haemost 2013;11: 615-26.
15. Lip GY. The role of aspirin for stroke prevention in atrial fibrillation. Nat Rev Cardiol 2011;8:602-6.
16. Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation Cohort Study. Eur Heart J 2012;33:1500-10.
17. Sullivan RM, Zhang J, Zamba G, Lip GY, Olshansky B. Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from affirm). Am J Cardiol 2012;110:1799-802.
18. Hart RG, Eikelboom JW, Pearce LA. Sex, stroke, and atrial fibrillation. Arch Neurol 2012;69:1641-3.
19. Olesen JB, Lip GY, Kamper AL, Hommel K, Kober L, Lane DA, et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med 2012;367:625-35.
20. Lip GY, Bongiorni MG, Dobreanu D, Lewalter T, Hastrup Svendsen J, Blomstrom-Lundqvist C. Novel oral anticoagulants for stroke prevention in atrial fibrillation: